Do Kenny, Kawana Eric, Shah Suparna, Salinas Jonathan, Bigcas Jo-Lawrence
Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV, USA.
Department of Otolaryngology-Head & Neck Surgery, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, USA.
J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251314789. doi: 10.1177/19160216251314789.
Adult laryngeal hemangiomas are rare and may cause symptoms such as dysphonia, dysphagia, and dyspnea. Carbon dioxide (CO2) lasers offer an alternative approach to managing this rare condition.
The objective of this study is to evaluate the effectiveness of CO2 lasers in treating adult hemangioma and to identify potential side effects associated with this treatment modality.
DESIGN/METHODS: The study utilizes the PRISMA model to systematically collect articles available in the current literature. The numbers obtained from each academic manuscript were then used to calculate the effectiveness of CO2 laser therapy in patients with laryngeal hemangiomas. Articles from 1949 to 2023 were gathered using the PRISMA systematic review method.
Not applicable.
Adult patients with laryngeal hemangioma who were treated with CO2 lasers.
Surgical management with CO2 lasers.
Number of patients with at least a 50% reduction in laryngeal hemangioma size.
Two case reports, 4 case series, and 2 observational studies were included in this systematic review. For the case reports and series, only 1 out of the 19 patients experienced recurrence following CO2 laser treatment. However, some studies did not have adequate follow-up time. In the 2 observational studies, efficacy rates of 100% and 90.9% were reported by the authors respectively.
Adult laryngeal hemangioma can be safely and successfully treated with CO2 laser microsurgery in well-selected cases. More studies, as well as longer patient follow-ups, are needed to truly assess the efficacy of CO2 laser in treating laryngeal hemangioma. This method provides a minimally invasive technique for adult patients with this rare disease.
成人喉血管瘤较为罕见，可能会引发声音嘶哑、吞咽困难和呼吸困难等症状。二氧化碳（CO2）激光为治疗这种罕见病症提供了一种替代方法。
本研究旨在评估CO2激光治疗成人血管瘤的有效性，并确定与这种治疗方式相关的潜在副作用。
设计/方法：本研究采用PRISMA模型系统收集当前文献中可用的文章。然后，从每篇学术手稿中获取的数据用于计算CO2激光治疗喉血管瘤患者的有效性。使用PRISMA系统评价方法收集了1949年至2023年的文章。
不适用。
接受CO2激光治疗的成人喉血管瘤患者。
采用CO2激光进行手术治疗。
喉血管瘤大小至少减少50%的患者数量。
本系统评价纳入了2篇病例报告、4篇病例系列和2项观察性研究。对于病例报告和系列，19例患者中只有1例在CO2激光治疗后出现复发。然而，一些研究的随访时间不足。在2项观察性研究中，作者分别报告了100%和90.9%的有效率。
在精心挑选的病例中，成人喉血管瘤可以通过CO2激光显微手术安全、成功地进行治疗。需要更多的研究以及更长时间的患者随访，以真正评估CO2激光治疗喉血管瘤的疗效。这种方法为患有这种罕见疾病的成人患者提供了一种微创技术。
